SPDR Biotech ETF (XBI)

SPDR Biotech ETF (XBI $86.27)
- $86.27 Fwd P/E: 25.15X Cap: $5.06B
- View XBI Profile
- View Questions on XBI

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Home Depot Inc. (The) (HD $359.40)
- $359.40 Fwd P/E: 24.37X Cap: $357.57B
- View HD Profile
- View Questions on HD
Nike Inc. (NKE $72.47)
- $72.47 Fwd P/E: 24.25X Cap: $106.96B
- View NKE Profile
- View Questions on NKE
United Airlines Holdings Inc. (UAL $92.25)
- $92.25 Fwd P/E: 8.3X Cap: $30.12B
- View UAL Profile
- View Questions on UAL
Suncor Energy Inc. (SU $53.31)
- $53.31 Fwd P/E: 10.85X Cap: $65.44B
- View SU Profile
- View Questions on SU
Canadian Natural Resources Limited (CNQ $42.30)
- $42.30 Fwd P/E: 11.94X Cap: $88.54B
- View CNQ Profile
- View Questions on CNQ
Cenovus Energy Inc. (CVE $19.31)
- $19.31 Fwd P/E: 12.87X Cap: $35.19B
- View CVE Profile
- View Questions on CVE
Air Canada Voting and Variable Voting Shares (AC $20.99)
- $20.99 Fwd P/E: 4.87X Cap: $6.77B
- View AC Profile
- View Questions on AC
Teck Resources Limited Class B Subordinate Voting Shares (TECK.B $51.48)
- $51.48 Fwd P/E: 61.95X Cap: $25.63B
- View TECK.B Profile
- View Questions on TECK.B
Secure Waste Infrastructure Corp. (SES $16.48)
- $16.48 Fwd P/E: 19.83X Cap: $3.80B
- View SES Profile
- View Questions on SES
Capstone Copper Corp. (CS $7.74)
- $7.74 Fwd P/E: 52.18X Cap: $5.89B
- View CS Profile
- View Questions on CS
SPDR Biotech ETF (XBI $86.27)
- $86.27 Fwd P/E: 25.15X Cap: $5.06B
- View XBI Profile
- View Questions on XBI
Crocs Inc. (CROX $105.18)
- $105.18 Fwd P/E: 6.53X Cap: $5.97B
- View CROX Profile
- View Questions on CROX
Deckers Outdoor Corporation (DECK $101.91)
- $101.91 Fwd P/E: 15.96X Cap: $15.12B
- View DECK Profile
- View Questions on DECK
Stellantis N.V. (STLA $9.20)
- $9.20 Cap: $27.10B
- View STLA Profile
- View Questions on STLA

Q: Sell or not, and proxy for sales in your opinion.
AC, TECK.B, CS, SES, STLA, ARE, CVE.
XBI-N, HD-N, NIKE-N,

Read Answer Asked by Nizar on April 30, 2025

iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $61.60)
- $61.60 Fwd P/E: 28.3X Cap: $523M
- View XHC Profile
- View Questions on XHC
iShares U.S. Medical Devices ETF (IHI $60.06)
- $60.06 Fwd P/E: 105.73X Cap: $4.31B
- View IHI Profile
- View Questions on IHI
SPDR Biotech ETF (XBI $86.27)
- $86.27 Fwd P/E: 25.15X Cap: $5.06B
- View XBI Profile
- View Questions on XBI

Q: Greetings…I’ve taken a 10% haircut on this ETF held for healthcare exposure. I could book the loss, but if I replace with another healthcare ETF inside of 30 days in your experience does the CRA have a problem with that? Also, some of the other ETF’s on the TSX look like they have fared even worse. Any ideas? (Trying to avoid holding one or two US companies individually)

Read Answer Asked by Stephen R. on April 23, 2025

iShares Biotechnology ETF (IBB $129.73)
- $129.73 Fwd P/E: 41.5X Cap: $5.50B
- View IBB Profile
- View Questions on IBB
SPDR Biotech ETF (XBI $86.27)
- $86.27 Fwd P/E: 25.15X Cap: $5.06B
- View XBI Profile
- View Questions on XBI
Natera Inc. (NTRA $138.90)
- $138.90 Cap: $19.57B
- View NTRA Profile
- View Questions on NTRA
ARK Genomic Revolution ETF (ARKG $24.92)
- $24.92 Fwd P/E: 20.56X Cap: $991M
- View ARKG Profile
- View Questions on ARKG
Catalyst Pharmaceuticals Inc. (CPRX $21.03)
- $21.03 Fwd P/E: 13.66X Cap: $2.61B
- View CPRX Profile
- View Questions on CPRX

Q: It looks like biotech stocks are on a tear, especially those that may benefit from AI. Do you have any names that you might recommend? I'm considering the Arkg fund but I don't quite trust Cathy Woods after losing money on the Arkk fund in 2021. Thank you,

Jason

Read Answer Asked by Jason on February 18, 2025